196 related articles for article (PubMed ID: 31307954)
1. MDR1 gene polymorphisms and acute myeloid leukemia AML susceptibility in A Moroccan adult population: A case-control study and meta-analysis.
Kaltoum ABO; Sellama N; Hind D; Yaya K; Mouna L; Asma Q
Curr Res Transl Med; 2020 Jan; 68(1):29-35. PubMed ID: 31307954
[TBL] [Abstract][Full Text] [Related]
2. Association of Multidrug Resistance Gene-1 (MDR1 C1236T) Polymorphism with the Risk of Acute Myeloid Leukemia in a Moroccan Population.
Ait Boujmia OK; Nadifi S; Dehbi H; Lamchahab M; Quessar A
Asian Pac J Cancer Prev; 2020 Jul; 21(7):1899-1904. PubMed ID: 32711413
[TBL] [Abstract][Full Text] [Related]
3. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia.
Yaya K; Hind D; Meryem Q; Asma Q; Said B; Sellama N
Tumour Biol; 2014 Nov; 35(11):10969-75. PubMed ID: 25087925
[TBL] [Abstract][Full Text] [Related]
5. The influence of DNMT3A and DNMT3B gene polymorphisms on acute myeloid leukemia risk in a Moroccan population.
Ait Boujmia OK; Nadifi S; Dehbi H; Lamchahab M; Quessar A
Curr Res Transl Med; 2020 Nov; 68(4):191-195. PubMed ID: 32912818
[TBL] [Abstract][Full Text] [Related]
6. Association of an MDR1 gene (C3435T) polymorphism with acute leukemia in India.
Rao DN; Anuradha C; Vishnupriya S; Sailaja K; Surekha D; Raghunadharao D; Rajappa S
Asian Pac J Cancer Prev; 2010; 11(4):1063-6. PubMed ID: 21133625
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 (1082G/A) Polymorphism is Associated with Susceptibility of Acute Myeloid Leukemia Patients in Sudanese Population.
Sharif OM; Hassan R; Mohammed Basbaeen AA; Mohmed AH; Ibrahim IK
Asian Pac J Cancer Prev; 2019 Jul; 20(7):1939-1943. PubMed ID: 31350948
[TBL] [Abstract][Full Text] [Related]
8. Association of CYP2B6 G15631T polymorphism with acute leukemia susceptibility.
Berköz M; Yalin S
Leuk Res; 2009 Jul; 33(7):919-23. PubMed ID: 19144407
[TBL] [Abstract][Full Text] [Related]
9. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
Liu L; Yang L; Mi Y; Wang J; Li J; Zhang Y; Ma X; Qin T; Xu Z; Xiao Z
Leuk Res; 2011 Aug; 35(8):1020-6. PubMed ID: 21296419
[TBL] [Abstract][Full Text] [Related]
10. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between MDR1 genetic polymorphism and prognosis in acute myeloid leukemia].
Wang D; Ke XY; Wang J; Xu F; Hu YF
Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1384-8. PubMed ID: 17785057
[TBL] [Abstract][Full Text] [Related]
12. XRCC3 Thr241Met polymorphism and risk of acute myeloid leukemia in a Romanian population.
Bănescu C; Tilinca M; Benedek EL; Demian S; Macarie I; Duicu C; Dobreanu M
Gene; 2013 Sep; 526(2):478-83. PubMed ID: 23747401
[TBL] [Abstract][Full Text] [Related]
13. Clinical Implication of Toll-Like Receptors (TLR2 and TLR4) in Acute Myeloid Leukemia Patients.
Aref S; Abd Elmaksoud ASM; Abd Elaziz S; Mabed M; Ayed M
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3177-3183. PubMed ID: 33247673
[TBL] [Abstract][Full Text] [Related]
14. Association of C3435T, C1236T and C4125A Polymorphisms of the MDR-1 Gene in Egyptian Children with Acute Lymphoblastic Leukaemia.
Talaat RM; Y K El-Kelliny M; El-Akhras BA; Bakry RM; Riad KF; Guirgis AA
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2535-2543. PubMed ID: 30256048
[TBL] [Abstract][Full Text] [Related]
15. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.
Cascorbi I; Gerloff T; Johne A; Meisel C; Hoffmeyer S; Schwab M; Schaeffeler E; Eichelbaum M; Brinkmann U; Roots I
Clin Pharmacol Ther; 2001 Mar; 69(3):169-74. PubMed ID: 11240981
[TBL] [Abstract][Full Text] [Related]
16. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
Illmer T; Schuler US; Thiede C; Schwarz UI; Kim RB; Gotthard S; Freund D; Schäkel U; Ehninger G; Schaich M
Cancer Res; 2002 Sep; 62(17):4955-62. PubMed ID: 12208746
[TBL] [Abstract][Full Text] [Related]
17. Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids.
Youssef DM; Attia TA; El-Shal AS; Abduelometty FA
Gene; 2013 Nov; 530(2):201-7. PubMed ID: 23994685
[TBL] [Abstract][Full Text] [Related]
18. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
19. Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients.
Bozina N; Kuzman MR; Medved V; Jovanovic N; Sertic J; Hotujac L
J Psychiatr Res; 2008 Jan; 42(2):89-97. PubMed ID: 17113599
[TBL] [Abstract][Full Text] [Related]
20. NBS1 rs1805794G>C polymorphism is associated with decreased risk of acute myeloid leukemia in a Chinese population.
Li N; Xu Y; Zheng J; Jiang L; You Y; Wu H; Li W; Wu D; Zhou Y
Mol Biol Rep; 2013 May; 40(5):3749-56. PubMed ID: 23283743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
